SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-022043
Filing Date
2021-04-29
Accepted
2021-04-29 17:00:38
Documents
4
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A stro-def14a_20210406.htm DEF 14A 1084765
2 GRAPHIC glpc4eoahvbm000003.jpg GRAPHIC 167897
3 GRAPHIC glpc4eoahvbm000002.jpg GRAPHIC 416336
4 GRAPHIC glpc4eoahvbm000001.jpg GRAPHIC 19154
  Complete submission text file 0001564590-21-022043.txt   1916665
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38662 | Film No.: 21871765
SIC: 2836 Biological Products, (No Diagnostic Substances)